Warning about fake weight loss pills and injections as research finds 684% increase in monthly enforcement action
The arrival of the first GLP-1 weight loss pill on the UK high street marks a major milestone in obesity treatment – but the opportunity for counterfeiters to cash in is rising.
New data from Corsearch reveals that enforcement numbers against illicit GLP-1 listings across its monitored portfolio increased 684% between February and July 2026.
This underlines the scale of the threat already facing the sector, with online marketplaces accounting for 58% of all detected infringements, followed by social media at 27%.
The data also highlights how criminals are exploiting consumers looking for easier access to weight-loss medication.
35% of GLP-1 enforcement actions involved listings offering medicines without a prescription, making prescription bypass the leading infringement type, followed by trademark infringement at 33%.
- With weight loss medication now available in both injectable and pill form, is there more opportunities than ever to sell fakes?
- How dangerous are fakes?
- Any advice for consumers?
Responses by tomorrow morning.


